ResMed Stock Price - RMD

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
After Hours
Last Trade
Last $ 144.15 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
ResMed Inc RMD NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.27 0.19% 144.15 145.75 143.36 143.60 143.88 17:59:46
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,152 325,334 $ 144.50 $ 47,010,743 543,787 90.64 - 149.96
Last Trade Time Type Quantity Stock Price Currency
18:29:41 32,031 $ 144.15 USD

ResMed Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 20.73B 143.79M $ 315.59M 2.79 51.30 141.34M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.31M $ 0.74 0.51% 11/06/19 - -

more financials information »

ResMed News

Loading Messages....

Latest RMD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RMD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week147.50147.50141.38143.34473,277-3.35-2.27%
1 Month130.01149.96126.26140.16573,43014.1410.88%
3 Months136.37149.96126.26136.23520,2097.785.71%
6 Months110.42149.96109.10128.58523,83133.7330.55%
1 Year106.77149.9690.64112.54734,20737.3835.01%
3 Years59.64149.9657.4594.66667,38284.51141.7%
5 Years51.13149.9648.9978.10756,46493.02181.93%

ResMed Description

ResMed Inc is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payor in the out-of-hospital setting.


Your Recent History
NYSE
RMD
ResMed
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.